HER2‑positive breast cancer that resists therapeutic drugs and ionizing radiation releases sphingomyelin‑based molecules to circulating blood serum

Satoru Monzen(Hirosaki University), Lovisa Lundholm(Karolinska University Hospital)
Molecular and Clinical Oncology
September 21, 2020
Cited by 6


Related Papers